IMPAIRED RESPONSIVENESS TO FOLINIC ACID PROTECTION IN METHOTREXATE-RESISTANT L5178Y CELLS

被引：14

作者：

GOLDIE, JH

HARRISON, SI

PRICE, LA

HILL, BT

机构：

[1] ST MICHAELS HOSP,DEPT MED,TORONTO,ONTARIO,CANADA

[2] UNIV TORONTO,TORONTO,ONTARIO,CANADA

来源：

EUROPEAN JOURNAL OF CANCER | 1975年 / 11卷 / 09期

关键词：

D O I：

10.1016/0014-2964(75)90097-3

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：627 / 632

页数：6

共 16 条

[1]

BORSA J, 1969, MOL PHARMACOL, V5, P318

[2]

BORSA J, 1969, MOL PHARMACOL, V5, P303

[3]

CHU MY, 1968, BIOCHEM PHARMACOL, V17, P753

[4] DEFECTIVE TRANSPORT OF AMETHOPTERIN (METHOTREXATE) AS A MECHANISM OF RESISTANCE TO ANTIMETABOLITE IN L5178Y LEUKEMIC CELLS [J].

FISCHER, GA .

BIOCHEMICAL PHARMACOLOGY, 1962, 11 (DEC) :1233-&

[5] COMPARISON OF EFFECTS OF METHOTREXATE AND PYRIMETHAMINE ON L5178Y LYMPHOBLASTS IN CELL-CULTURE [J].

GOLDIE, JH ;

FURNESS, ME ;

PRICE, LA .

EUROPEAN JOURNAL OF CANCER, 1973, 9 (10) :709-715

[6] METHOTREXATE TOXICITY - CORRELATION WITH DURATION OF ADMINISTRATION, PLASMA LEVELS, DOSE AND EXCRETION PATTERN [J].

GOLDIE, JH ;

HARRAP, KR ;

PRICE, LA .

EUROPEAN JOURNAL OF CANCER, 1972, 8 (04) :409-&

[7] ERADICATION OF LEUKAEMIC CELLS (L1210) BY METHOTREXATE AND METHOTREXATE PLUS CITROVORUM FACTOR [J].

GOLDIN, A ;

VENDITTI, JM ;

KLINE, I ;

MANTEL, N .

NATURE, 1966, 212 (5070) :1548-&

[8]

GOLDIN A, 1955, CANCER RES, V15, P742

[9]

GOLDMAN ID, 1971, ANN NY ACAD SCI, V186, P400

[10]

HARRAP KR, 1971, ANN NY ACAD SCI, V186, P312

← 1 2 →